Metastatic malignant neoplasm to brain
Information
- Disease name
- Metastatic malignant neoplasm to brain
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00928226 | Completed | N/A | Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases | April 2009 | December 2019 |
| NCT01332929 | Completed | Phase 1 | Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis | June 2010 | July 2013 |
| NCT01705548 | Completed | N/A | Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis | September 24, 2012 | September 18, 2023 |
| NCT02038218 | Completed | Phase 2 | Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors | September 2013 | August 2020 |
| NCT04801342 | Recruiting | Phase 2 | Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases | April 1, 2021 | February 28, 2025 |
| NCT02896335 | Recruiting | Phase 2 | Palbociclib In Progressive Brain Metastases | February 14, 2017 | September 2025 |
| NCT02154529 | Terminated | Phase 1/Phase 2 | Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer | May 2014 | September 13, 2015 |
| NCT02393131 | Unknown status | N/A | Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases | March 3, 2015 | December 2020 |